Phosphodiesterase-mediated modulation of subcellular cAMP levels to reduce heart failure
- PMID: 38784972
- DOI: 10.1093/cvr/cvae108
Phosphodiesterase-mediated modulation of subcellular cAMP levels to reduce heart failure
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation.Cardiovasc Res. 2024 Jul 31;120(9):1011-1023. doi: 10.1093/cvr/cvae094. Cardiovasc Res. 2024. PMID: 38776406
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical